<DOC>
	<DOCNO>NCT01937221</DOCNO>
	<brief_summary>The goal study create new retinal imaging processing software useful development novel retinal biomarkers cognitive impairment associate Alzheimer 's disease ( AD ) .</brief_summary>
	<brief_title>Novel Retinal Imaging Biomarkers Early Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>1 . Result standard neuropsychological assessment 2 . Are men postmenopausal woman , least 55 year age . Postmenopausal woman define woman hysterectomy and/or bilateral oophorectomy ; amenorrheic least 2 year ; 3 . Fluency English 4 . Participants mild cognitive impairment ( MCI ) /prodromal mildtomoderate dementia group must assign surrogate purpose inform consent help protocol compliance . 1 . Known suspected diagnosis nonAD , associate dementia ; 2 . Major ophthalmologic comorbidities : Ruptured globe , retinal vascular occlusive disease , retinal artery occlusion , anterior ischemic optic neuropathy , medium opacification due corneal abnormality cataract prevent ocular OCT examination , glaucoma , wet ( neovascular ) agerelated macular degeneration , history intravitreal injection , macular edema . If two eye satisfy inclusion criterion , eye include study .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>mild cognitive impairment</keyword>
	<keyword>mild moderate cognitive impairment</keyword>
</DOC>